1
/
of
0
FDA Drug Approval, N217003, IMBRUVICA
FDA Drug Approval, N217003, IMBRUVICA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 217003
Company: PHARMACYCLICS LLC
Drug Name: IMBRUVICA
Active Ingredients: IBRUTINIB
Strength: 560MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/24/2022
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: PHARMACYCLICS LLC
Drug Name: IMBRUVICA
Active Ingredients: IBRUTINIB
Strength: 560MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/24/2022
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details